New Insulins, Biosimilars, and Insulin Therapy

Diabetes Technol Ther. 2023 Feb;25(S1):S44-S69. doi: 10.1089/dia.2023.2504.

Authors

Thomas Danne¹, Lutz Heinemann², Thomas R Pieber³

Affiliations

¹ Diabetes-Zentrum für Kinder and Jugendliche, Kinder- und Jugendkrankenhaus "AUF DER BULT", Hannover, Germany.
² Science Consulting in Diabetes GmbH, Kaarst, Germany.
³ Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

PMID: 36802184
DOI: 10.1089/dia.2023.2504

No abstract available

MeSH terms

Biosimilar Pharmaceuticals* / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin, Regular, Human
Insulins* / therapeutic use

Substances

Insulin
Biosimilar Pharmaceuticals
Insulins
Hypoglycemic Agents
Insulin, Regular, Human